Sign In Contact Us
Act with Confidence

Late Phase Market Dynamics

Market dynamics and service assessments for the late stage market

Q1, 2010

This study is a landmark study based on interviews with 149 decision-makers from around the world representing 95 unique pharma and biotech companies.

Respondents discuss in detail their plans for study conduct and outsourcing across various Late Phase study categories. In addition, respondents provide their perceptions of - and experiences with - dozens of Late Phase service providers. The report contains 153 pages, including novel and insightful analyses and nearly 200 charts and graphs.

Report Content

This report contains the following three sections:

  • Late Phase Trends and Market Sizing
  • Service Provider Dynamics
  • Decision Making for Late Phase Studies

What Readers Will Learn

  • Late Phase market size and growth potential
  • Late Phase service provider service quality and customer loyalty 
  • What drives sponsors' selection of Late Phase service providers 
  • What drives sponsors' satisfaction with Late Phase service delivery 
  • The complex decision-making units within sponsor companies

Sample Graph 

report_chartsample_latephase.png 

Other Measurements Reported

  • Growth and decline in study conduct and outsourcing
  • ePRO and Electronic Health Record Trends
  • Innovation in Late Phase
  • Service Providers Leading in Late Phase 
  • Service Provider Usage
  • Service Provider Quality / Performance
  • Service Provider Loyalty
  • Drivers for late phase study conduct
  • Sponsors’ Departmental responsibilities
  • Service Provider selection by study type

Companies Profiled

  • Covance
  • i3 Pharma Services
  • ICON
  • Kendle (INC Research)
  • PAREXEL
  • PPD
  • PRA
  • Quintiles
  • UBC

Similar Reports

Purchasers of this report also purchased: